HUP0100132A2 - A béta-lipotropin és felhasználása - Google Patents

A béta-lipotropin és felhasználása

Info

Publication number
HUP0100132A2
HUP0100132A2 HU0100132A HUP0100132A HUP0100132A2 HU P0100132 A2 HUP0100132 A2 HU P0100132A2 HU 0100132 A HU0100132 A HU 0100132A HU P0100132 A HUP0100132 A HU P0100132A HU P0100132 A2 HUP0100132 A2 HU P0100132A2
Authority
HU
Hungary
Prior art keywords
lipotropin
beta
subject
betha
fragments
Prior art date
Application number
HU0100132A
Other languages
English (en)
Inventor
Gerald Wayne Becker
Jon Paul Butler
John Edward Hale
William Francis Junior Heath
Mark Louis Heiman
Brigitte Elisabeth Schoner
Alexander David Varshavsky
Original Assignee
Eli Lilly And Co.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly And Co. filed Critical Eli Lilly And Co.
Publication of HUP0100132A2 publication Critical patent/HUP0100132A2/hu

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/33Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C07K14/67Lipotropins, e.g. beta, gamma lipotropin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Immunology (AREA)
  • Endocrinology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)

Abstract

A találmány tárgyát a béta-lipotropinnal kapcsolatban levő izoláltnukleinsavak, vektorok, transzformált gazdasejtek, analógok,funkcionális fragmensek és fúziós fehérjék képezik. A találmánytárgyát képezik továbbá a béta-lipotropint vagy fragmenseit és/vagyanalógjait tartalmazó gyógyászati készítmények, valamint acukorbetegség és annak komplikációi kezelésére alkalmas eljárások, abéta-lipotropin hatékony mennyiségének beadásával. Ó
HU0100132A 1997-12-23 1998-12-21 A béta-lipotropin és felhasználása HUP0100132A2 (hu)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US6865997P 1997-12-23 1997-12-23
US7985798P 1998-03-30 1998-03-30
US8632198P 1998-05-21 1998-05-21
US9138598P 1998-07-01 1998-07-01
US9540598P 1998-08-05 1998-08-05
US10397698P 1998-10-13 1998-10-13
PCT/US1998/027238 WO1999032142A1 (en) 1997-12-23 1998-12-21 Beta-lipotropin and uses thereof

Publications (1)

Publication Number Publication Date
HUP0100132A2 true HUP0100132A2 (hu) 2001-05-28

Family

ID=27557000

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0100132A HUP0100132A2 (hu) 1997-12-23 1998-12-21 A béta-lipotropin és felhasználása

Country Status (18)

Country Link
US (2) US6323178B1 (hu)
EP (1) EP0926239A3 (hu)
JP (1) JP2001526061A (hu)
KR (1) KR20010024805A (hu)
CN (1) CN1284882A (hu)
AR (1) AR018532A1 (hu)
AU (1) AU1938599A (hu)
BR (1) BR9814433A (hu)
CA (1) CA2315888A1 (hu)
CO (1) CO4930304A1 (hu)
EA (1) EA200000709A1 (hu)
HR (1) HRP20000426A2 (hu)
HU (1) HUP0100132A2 (hu)
IL (1) IL136514A0 (hu)
PE (1) PE20000062A1 (hu)
PL (1) PL341293A1 (hu)
TR (1) TR200002611T2 (hu)
WO (1) WO1999032142A1 (hu)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2428216A1 (en) * 2000-12-13 2002-06-20 Incyte Genomics, Inc. Secreted proteins
US7910101B2 (en) 2004-10-25 2011-03-22 Centocor, Inc. Melanocortin receptor binding mimetibodies, compositions, methods and uses
US8227194B2 (en) * 2005-04-08 2012-07-24 University Of Maryland, Baltimore Monoclonal antibodies with binding specificity for response gene to complement 32 (RGC-32)
US20090281519A1 (en) * 2008-05-12 2009-11-12 Rao R Harsha Automated system and method for diabetes control

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4769326A (en) 1980-02-29 1988-09-06 The Regents Of The University Of California Expression linkers
US5258496A (en) * 1990-07-10 1993-11-02 Scios Nova Inc. Isolation and purification of lung surfactant protein
JP3822232B2 (ja) * 1993-08-30 2006-09-13 ベイラー・カレッジ・オブ・メディシン 老化細胞由来dna合成阻害因子
US5478852C1 (en) 1993-09-15 2001-03-13 Sankyo Co Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of impaired glucose tolerance in order to prevent or delay the onset of noninsulin-dependent diabetes mellitus
US5691309A (en) 1995-01-31 1997-11-25 Eli Lilly And Company Anti-obesity proteins

Also Published As

Publication number Publication date
TR200002611T2 (tr) 2000-12-21
BR9814433A (pt) 2000-10-10
AU1938599A (en) 1999-07-12
WO1999032142A1 (en) 1999-07-01
JP2001526061A (ja) 2001-12-18
KR20010024805A (ko) 2001-03-26
CN1284882A (zh) 2001-02-21
US20030073621A1 (en) 2003-04-17
US6323178B1 (en) 2001-11-27
CA2315888A1 (en) 1999-07-01
PE20000062A1 (es) 2000-02-08
EP0926239A3 (en) 2002-08-28
EP0926239A2 (en) 1999-06-30
CO4930304A1 (es) 2000-06-27
PL341293A1 (en) 2001-04-09
EA200000709A1 (ru) 2000-12-25
HRP20000426A2 (en) 2000-10-31
AR018532A1 (es) 2001-11-28
IL136514A0 (en) 2001-06-14

Similar Documents

Publication Publication Date Title
RU95115239A (ru) Аналог эритропоэтина
DE69434166D1 (de) Menschliche metabotropische glutamatrezeptor untertype hmglur7 und verwandte dns-verbindungen
HUP0100928A2 (hu) Humán inzulin B láncának részletét tartalmazó peptidanalógok, ezeket tartalmazó gyógyászati készítmények és alkalmazásuk
DE3676670D1 (de) Solubilisierung von proteinen fuer pharmazeutische zusammensetzungen mittels polymerkonjugierung.
DE69435075D1 (de) , die signalsequenzpeptide des endoplasmatischen reticulums und mindestens ein anderes peptid codieren, deren verwendung in impfstoffen und zur behandlung von krankheiten
BR9814276A (pt) Antìgenos de superfìcie
HUP0104889A2 (hu) Telomerázból származó antigenikus peptidek
HUP0203409A2 (hu) Gamma-interferon-konjugátumok
HUP0105303A2 (en) Her-2/neu fusion proteins
ATE194291T1 (de) Neutralisierende monoklonale antikörper gegen respiratorischen synzytialvirus
BR9710452A (pt) Anïïlogos de exendina processos para sua prepara-Æo e medicamentos contendo os mesmos
BR9810907A (pt) Anticorpos monoclonais e policlonais, peptìdeo suscetìvel de gerar um anticorpo, agente imunogênico, sequência de nucleotìdeos, composição farmacêutica, uso de pelo menos um anticorpo, kit de diagnóstico, e, processo para preparar um agente imunogênico
DK1650304T3 (da) Kloning og rekombinant fremstilling af vespidgiftphospholipase og immunologiske terapier baseret derpå
DK1025237T3 (da) Human kontrolpunktskinase, hCDS1, præparater og fremgangsmåder
BR9508467A (pt) Composição de matéria peptídeo de ligação de receptor de somatostatina composição farmacéutica e processo para realizar uma cirurgia guiada por radiosótopos ou um procedimento de radiodiagnóstico ou radioterapéutico e para aliviar uma doença relacionada com somatostetina em um animal
DK610888D0 (da) Cardiodilatinfragmentet, fremgangsmaade til fremstilling deraf samt dets anvendelse
HUP9802961A2 (hu) Kötési partner ciklinfüggő kinázok inhibitoraihoz és ezek alkalmazása inhibitorok kereséséhez, valamint egy betegség diagnózisához vagy terápiájához
IL80562A0 (en) Recombinant human lysozyme,its preparation by recombinant dna technology and pharmaceutical compositions containing it
HUP0100132A2 (hu) A béta-lipotropin és felhasználása
EP0378929A3 (en) Membrane proteins and peptides of haemophilus influenzae type b
PT83837B (pt) Processo para a preparacao de peptideos por utilizacao de percloratos
DK0616642T3 (da) Hidtil ukendte thrombininhibitoriske proteiner fra landblodigler
AU1318797A (en) Peptides and uses thereof for therapy of celiac diseases
EP0341661A3 (en) Peptide-drug compositions containing alpha-aminoboronic acid derivatives
AU6393990A (en) Hiv related peptides